Walmart is about 33% of the entire beauty business in the mass market. CVS and Walgreens and Target, those four together make up about 75% of the syndicated data in the market. Walgreens would be second largest, CVS would be third, but that teeters back and forth, as far as volume is concerned, and I think CVS may have taken over Walgreens this past year. I have to wait till the 2018 data comes through. Then Target also has a great business here and is the darling of the industry, as far as top line growth is concerned.
I think there will be continued pressure there because their operating income continues to shrink, which is what's been causing some dings to their share price, which they can get margin out of several different ways. They can cut their SG&A, but they can also ask for an increase from the supplier community to offset some of that. Everybody start your business or, if you want to be considered a beauty player, you would have distribution at Ulta versus any of the big four.
They're not as attractive because the cost to serve is so much higher. Whatever happens with Ulta on their margin requirements going forward, they may be considered very high cost to serve in the future versus what the payback's going to be. Then you have e-commerce, where Amazon is a massive player, undisclosed amounts of money, but it's multi-billions for their beauty and personal care business. A couple of billion sits outside that's not recognized in the Amazon business, and they're fairly decent to do business with, as far as the margin structure's concerned.
Yes, the trade fuel that you would spend. The cost to do business with the drug retailers is the highest, and then Walmart and Amazon are the lowest, and Target and Ulta sit in the middle. Then you've got off-discounters, like the value distribution channel etc., that have a good-sized business. I know Ross [Ross Stores Inc.] has 500 million or a billion, that they take out the market.
Ross does around 14 billion, as a total store. You don't see it go through any syndicated data, but I know that's how big their business is, so you take that out of the market.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities.
© 2024 IP 1 Ltd. All rights reserved.